@artsinyci
iAccount based inGreece
About this account
- Account based in
- Greece
- Connected via
- United States Android App
Account-level information from X, not a live location or the device used for a specific post.
Precision Medicine | Genomics | Epigenetics | Machine Learning Professor of Medicine and Pathology @NYUGSOM_PMED @nyugrossman
New York
Joined September 2010
- Tweets305
- Following619
- Followers1.4K
- Likes902
Pinned Tweet
Curious about AI's potential in Pathology? Discover how self-supervised AI autonomously learns histologic patterns: no need for experts to perform tedious annotations! Dive into our latest research: rdcu.be/dKtEp #PrecisionPathology @NYUGSOM_PMED @NYUGSOM_Path
Aristotelis Tsirigos retweeted
Our lab together with @artsinyc has spent the last ~15 years focusing on 3D chromosomal architecture in human leukemia and it is exciting to see 3D assays been introduced also in clinical/diagnostic settings.
The work was supported by @theNCI and @nyugrossman Huge thanks to @_TanyaBondar_ for guidance and advice.
#ALL #Leukemia #PediatricCancer #TranslationalResearch #Chromatin #cancer
Thrilled to host Dr. Michael Snyder at NYU Langone for Medicine Grand Rounds. Together with Dr. Morgan Grams, we welcomed a true pioneer in genomics and precision medicine, whose work continues to shape the future of data-driven, personalized care.
@NYUGSOM_PMED
Aristotelis Tsirigos retweeted
KRAS inhibitors have been used to treat pancreatic cancer, but can they PREVENT cancer from occurring altogether? In @ScienceMagazine from @PennCancer
Cancer interception with KRAS inhibitors in preclinical models of #PancreaticCancer
science.org/doi/10.1126/scie…
Aristotelis Tsirigos retweeted
Gaucher's Disease: A bone marrow aspirate shows lipid-laden macrophages AKA "wrinkled tissue paper" or "crumpled silk" (Gaucher cells). The BM aspirate may give you diagnostic clues to enzyme deficiencies and storage disorders. 🦴🩸🧬🔬 Image from @StanleySchrier & ASH Image Bank! #MedEd #Hematology #ASHImageBank #hemepath imagebank.hematology.org/ima…
@KMirza @artsinyc
Aristotelis Tsirigos retweeted
Monoclonal kappa light chain staining of plasma cells🔬 indicates a plasma cell proliferation, as seen here. Image: Marshall Kadin/ASH Image Bank. #MedEd #Hematology #ASHImageBank #hemepath imagebank.hematology.org/ima…
Aristotelis Tsirigos retweeted
APL variant morphology! 🧐 Less prominent granules & a bilobed/folded nucleus can be key for diagnosis. Don't miss subtle clues: FISH for PML::RARA (Peter Maslak; Susan McKenzie;) / ASH Image Bank #MedEd #Hematology #ASHImageBank #hemepath 🩸🔬 imagebank.hematology.org/ima…
@KMirza @artsinyc
We are using a human-in-the-loop AI workflow to randomly select cases and draft initial teaching pearls from the #ASHImageBank. Every post is carefully reviewed, edited, and approved by an expert hematopathologist before sharing. Feedback welcome 🩸#AIinMedicine #ExpertInTheLoop
Dear #hemepath aficionados, we have exciting news from #ASHImageBank 🤩We're using social media & AI to spotlight cases, recognize authors, & teach #hematology with weekly educational posts packed with teaching pearls. Be on the lookout & let's learn together! #PathTwitter
Aristotelis Tsirigos retweeted
Introducing Chromnitron, a multimodal transformer that learns and predicts genome-wide binding landscape for hundreds of DNA-binding proteins across cell types. We envision it as a platform for accelerating genomics research and biological discovery!
Aristotelis Tsirigos retweeted
🧵See threads by @BoXia7 for more details nitter.cf/BoXia7/status/20141059…
🙏 Huge thanks to the team: Xi Fu @alexanderfuxi , Xinyu Lin @Dennislxy , Aris Tsirigos @artsinyc , Bo Xia @BoXia7 , and coauthors!
💻 Try it on Colab github.com/tanjimin/Chromnit…
📄 Preprint biorxiv.org/content/10.1101/…
🧬 Another super exciting new work from the lab: Decoding the gene regulatory landscape through multimodal learning of protein–DNA interactions.
👉 Link to preprint: biorxiv.org/content/10.1101/…
In this work, we introduce Chromnitron, a biologically grounded multimodal foundation model that decodes the global gene regulatory landscape by hundreds to thousands of proteins binding in the genome.
⁉️ Why is this protein-centered view of regulatory genomics so important? DNA sequence 🧬provides the same genetic blueprint, but the regulatory logic that gives rise to diverse cell types and states – in both health and disease conditions – is executed by the 100s-1000s of chromatin proteins that differentially read the DNA sequences to establish cell-type-specific gene expression programs.
🤖 Chromnitron is specifically developed to decode this cell-type-specific regulatory logic. Designed to learn from the first principles that determines protein–DNA interactions in the cell, Chromnitron integrates 1) genomic DNA sequence, 2) cell-type-specific chromatin states, and importantly, 3) protein sequence-encoded structural features.
👨🏻💻 Through large-scale pre-training & fine-tuning with a finely curated atlas of high-quality datasets, Chromnitron learns the shared and protein-specific mechanisms of protein–DNA interactions, and thus can accurately predict the binding landscapes across hundreds of proteins in unseen cell types.
💡Chromnitron isn’t just accurate and cell-type-specific prediction — it is a discovery engine! With Chromnitron:
we identified novel regulators of T cell exhaustion (ZNF865 & ZNF766);
we reconstructed the dynamic regulatory landscapes of how global chromatin proteins orchestrate neurodevelopment.
🔮 Chromnitron represents a significant step toward predictive, interpretable, and mechanistic understanding of gene regulation and cell fate determination. We expect Chromnitron to accelerate discovery and engineering in regulatory genomics, particularly in human biology, and empower therapeutic opportunities.
🙏🏻 Last, this is another wonderful collaboration with Dr. Aristotelis Tsirigos @artsinyc, and led by the brilliant Drs. Jimin Tan @tan_jimin, Xi Fu @alexanderfuxi, and Xinyu Ling @Dennislxy, and many more co-authors and friends who helped make this work truly possible!
👉 Find out more about the model and discoveries (e.g. architecture, interpretability, benchmarking, generalizability, etc): biorxiv.org/content/10.1101/…
#MultimodalAI #GeneRegulation #TranscriptionFactor #RegulatoryGenomics #CellFate #AIinBiology
Congratulations to my mentee Dr. José Gabriel Barcia Durán on being selected by @ASH_Hematology to receive the ASH Scholar Award 🏆supporting early-career hematology researchers as they transition to independent investigators 🚀
#ASHAwards #Fight4Hematology🩸
From the Xia & Hansen labs! We used our C.Origami AI for high-throughput *in silico* screening & found ZNF654 & JMJD6 are key to 3D genome architecture! These factors define TAD boundaries alongside CTCF & cohesin. Read more! 🧬 #genomics #3Dgenome pubmed.ncbi.nlm.nih.gov/4141…
Aristotelis Tsirigos retweeted
NYU Digital Pathology
2025 Summary ⭐️⭐️
#pathtwitter
Thrilled to share highlights from #ASH25🩸Our #AI tools, C.Origami & Chromnitron, model 3D chromatin & protein-DNA binding to map gene regulation, conduct in silico perturbations & discover novel regulators @tan_jimin @BoXia7 @epigenetichulk @4DNucleome
Artificial Intelligence Healthcare Innovations, hosted by the Hellenic-American Chamber of Commerce & the Hellenic Medical Society of NY. I’ll be speaking with experts from NYU, Northwell, Microsoft & StoryMD on AI’s impact in healthcare.
📅Dec 2
🕡6:30 PM
📍Chiotes Hall, NYC
🔬 Our latest study shows how self-supervised learning uncovers links between histologic features, molecular phenotypes and clinical outcomes—without annotations! 🧬 AI-driven pathology brings us closer to precision medicine. nature.com/articles/s41467-0… @NYUGSOM_Path @NYUGSOM_PMED
Aristotelis Tsirigos retweeted
At Med #GrandRounds today @nyugrossman, Julie A. Johnson, Pharm.D of @OhioStateCTSI gave an outstanding talk on pharmacogenetics and its impact on drug therapy. She discussed key genes influencing drug response and how genotype-guided approaches can improve patient outcomes.
Key Takeaways:
▶️ Use of CPIC drugs is common, representing over 600M Rs and 150M people per year in the US - the largest potential for population impact among genomic medicine use cases
▶️ Evidence that genotype-guided approaches to drug therapy decisions can influence clinical outcomes
▶️ Pharmacogenetics should be viewed as a tool for optimizing drug therapy - not so different from serum creatinine for dosing of renally cleared drugs
▶️ Large, multicenter, randomized controlled trials will provide further evidence for the specific cases under study
▶️ Adoption barriers persist despite evidence
- Few cases of Pgx in medical discipline clinical practice guidelines
- Knowledge/confidence on the part of the prescriber still requires much work
- Tools for facile clinical implementation outside academic medical centers largely lacking
- Reimbursement for Px testing improving, but still a barrier (in reality or perception)
#MedTwitter #PublicHealth #MedEd #MedResearch #Pharmacogenetics #PrecisionMedicine #DrugTherapy #PersonalizedMedicine #ClinicalPharmacology
Aristotelis Tsirigos retweeted
Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma and Its Impact on Tumor Progression biorxiv.org/content/10.1101/… #biorxiv_cancer
Excited to share our latest in Nature BME! 🚀Led by @tan_jimin and with @DavidFenyo, we developed CANVAS—a vision transformer trained on single-cell spatial data to enable systematic studies of tumor heterogeneity: nature.com/articles/s41551-0…
We applied CANVAS to lung cancer imaging mass cytometry data from the @loganawalsh lab, uncovering a diverse spectrum of local tumor microenvironments (LTMEs) with high spatial resolution.